The Japan Sports Arbitration Agency on Tuesday announced it had accepted a plea by the Japan Anti-Doping Agency to have Japanese marathoner Kaori Yoshida’s suspension increased from one year to two.
Yoshida tested positive for the performance-enhancing drug erythropoietin (EPO) after finishing fourth at last December’s Honolulu Marathon. Yoshida claimed she had received medication from a doctor in November to treat anemia and it was unknown to her the prescription contained EPO.
Unable to view this article?
This could be due to a conflict with your ad-blocking or security software.
Please add japantimes.co.jp and piano.io to your list of allowed sites.
If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.
We humbly apologize for the inconvenience.